462 related articles for article (PubMed ID: 30954943)
21. Correlation between brain glucose metabolism (
Albano D; Premi E; Peli A; Camoni L; Bertagna F; Turrone R; Borroni B; Calhoun VD; Rodella C; Magoni M; Padovani A; Giubbini R; Paghera B
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(3):146-152. PubMed ID: 35577490
[TBL] [Abstract][Full Text] [Related]
22. [Value of (11)C-PiB PET/MRI in the evaluation of organ involvement in primary systemic light chain amyloidosis].
Wang YD; Yang YY; Wu YY; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):316-322. PubMed ID: 35680631
[No Abstract] [Full Text] [Related]
23. Visualization of multiple organ amyloid involvement in systemic amyloidosis using
Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012
[TBL] [Abstract][Full Text] [Related]
24. [18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Genovesi D; Vergaro G; Giorgetti A; Marzullo P; Scipioni M; Santarelli MF; Pucci A; Buda G; Volpi E; Emdin M
JACC Cardiovasc Imaging; 2021 Jan; 14(1):246-255. PubMed ID: 32771577
[TBL] [Abstract][Full Text] [Related]
25. Cardiac Amyloidosis Detected Using
García-González P; Cozar-Santiago MDP; Maceira AM
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1215. PubMed ID: 27178118
[No Abstract] [Full Text] [Related]
26. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
Datar Y; Clerc OF; Cuddy SAM; Kim S; Taylor A; Neri JC; Benz DC; Bianchi G; Yee AJ; Sanchorawala V; Ruberg FL; Landau H; Liao R; Kijewski MF; Jerosch-Herold M; Kwong RY; Di Carli MF; Falk RH; Dorbala S
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):687-697. PubMed ID: 38193678
[TBL] [Abstract][Full Text] [Related]
27. PET-CT evaluation of amyloid systemic involvement with [
Genovesi D; Vergaro G; Emdin M; Giorgetti A; Marzullo P
J Nucl Cardiol; 2017 Dec; 24(6):2025-2029. PubMed ID: 28326465
[TBL] [Abstract][Full Text] [Related]
28. Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?
Paghera B; Altomare D; Peli A; Morbelli S; Buschiazzo A; Bauckneht M; Giubbini R; Rodella C; Camoni L; Boccardi M; Festari C; Muscio C; Padovani A; Frisoni GB; Guerra UP
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):414-421. PubMed ID: 31089074
[TBL] [Abstract][Full Text] [Related]
29. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
[TBL] [Abstract][Full Text] [Related]
30. 18F-Florbetaben: A New Tool for Amyloidosis Staging?
D'Estanque E; Chambert B; Moranne O; Kotzki PO; Boudousq V
Clin Nucl Med; 2017 Jan; 42(1):50-53. PubMed ID: 27801739
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
32. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
33. Cardiac Amyloid Detection by PET/CT Imaging of Iodine (
Wall JS; Martin EB; Lands R; Ramchandren R; Stuckey A; Heidel RE; Whittle B; Powell D; Richey T; Williams AD; Foster JS; Guthrie S; Kennel SJ
JACC Cardiovasc Imaging; 2023 Nov; 16(11):1433-1448. PubMed ID: 37940323
[TBL] [Abstract][Full Text] [Related]
34. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
35. Repeatability of parametric methods for [
Verfaillie SC; Golla SS; Timmers T; Tuncel H; van der Weijden CW; Schober P; Schuit RC; van der Flier WM; Windhorst AD; Lammertsma AA; van Berckel BN; Boellaard R
J Cereb Blood Flow Metab; 2021 Mar; 41(3):569-578. PubMed ID: 32321347
[TBL] [Abstract][Full Text] [Related]
36. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.
Beach TG; Schneider JA; Sue LI; Serrano G; Dugger BN; Monsell SE; Kukull W
J Neuropathol Exp Neurol; 2014 Oct; 73(10):948-53. PubMed ID: 25192053
[TBL] [Abstract][Full Text] [Related]
37. Plasma Aβ analysis using magnetically-labeled immunoassays and PET
Wu KY; Hsiao IT; Chen CH; Liu CY; Hsu JL; Huang SY; Yen TC; Lin KJ
Sci Rep; 2018 Feb; 8(1):2739. PubMed ID: 29426824
[TBL] [Abstract][Full Text] [Related]
38. Amyloid PET imaging in cardiac amyloidosis: a pilot study using
Dietemann S; Nkoulou R
Ann Nucl Med; 2019 Aug; 33(8):624-628. PubMed ID: 31140154
[TBL] [Abstract][Full Text] [Related]
39. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
40. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.
Antoni G; Lubberink M; Estrada S; Axelsson J; Carlson K; Lindsjö L; Kero T; Långström B; Granstam SO; Rosengren S; Vedin O; Wassberg C; Wikström G; Westermark P; Sörensen J
J Nucl Med; 2013 Feb; 54(2):213-20. PubMed ID: 23238792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
